FDAnews Device Daily Bulletin

FDA OKs ‘Talking’ Injector

Aug. 16, 2012
The FDA has approved the first voice-guided epinephrine injection device (Auvi-Q) for treatment of severe allergic reactions. The device, which gives verbal step-by-step instructions, can be used by children weighing at least 33 pounds who are at risk for, or have a history of, anaphylaxis.
Everyday Health